A test designed to identify biomarkers associated with autism in infants and young children is now available to the public in most states. LinusBio, a New Jersey-based startup, on Thursday launched ...

Healthcare professionals in most regions of the US can order the test for women who previously had a child diagnosed with ...

Scientists have announced a first-of-its-kind diagnostic test for autism spectrum disorder (ASD) that only requires a single strand of hair. LinusBio, based in New Jersey, launched its Clearstrand-ASD ...

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early ...

Relying on a single strand of hair, LinusBio is launching its diagnostic aid for autism spectrum disorder—with a test designed to chart a child’s environmental exposures over time. The company aims to ...

The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) announced the official launch of the world's ...

Please provide your email address to receive an email when new articles are posted on . ClearStrand-ASD was designed to help clinicians rule out autism in children aged 1 to 36 months. The technology ...

Poorly controlled thyroid disease with persistent imbalance across trimesters is associated with an increased risk for autism ...

Background: Among patients with autism spectrum disorders (ASD) evaluated in our clinic, there appears to be a subset that can be clinically distinguished from other ASD children because of frequent ...

A test designed to identify biomarkers associated with autism just became available in most states. The test is meant to help physicians rule out autism in children who have higher likelihoods of it.